Aladdin Healthcare Technologies SE
Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer – first sales revenues of EUR 120,000
Aladdin Healthcare Technologies SE / Key word(s): Joint Venture Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer – first sales revenues of EUR 120,000
The goal of the joint venture (JV), in which Aladdin Healthcare holds a 51% stake, is the further global development and marketing of an AI-based drug discovery tool. The tool supports basic clinical research for the development of new drugs for age-related diseases such as Alzheimer’s, cardiovascular diseases, pulmonary diseases, diabetes and osteoporosis. At the same time, Aladdin has gained a new customer. The order volume for the use of the AI platform and for consultancy services is EUR 120,000.
Contact Press
29-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Aladdin Healthcare Technologies SE |
Unter den Linden 10 | |
10117 Berlin | |
Germany | |
Phone: | 030 700140449 |
E-mail: | info@aladdinid.com |
Internet: | www.aladdinid.com |
ISIN: | DE000A12ULL2 |
WKN: | A12ULL |
Listed: | Regulated Market in Dusseldorf |
EQS News ID: | 1032909 |
End of Announcement | DGAP News Service |